The estimated Net Worth of Michele Janis is at least $66.3 Thousand dollars as of 15 December 2022. Ms Janis owns over 1,015 units of OptiNose Inc stock worth over $45,013 and over the last 2 years she sold OPTN stock worth over $21,318.
Ms has made over 3 trades of the OptiNose Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she sold 1,015 units of OPTN stock worth $1,715 on 15 December 2022.
The largest trade she's ever made was selling 3,849 units of OptiNose Inc stock on 15 June 2022 worth over $13,433. On average, Ms trades about 2,201 units every 61 days since 2022. As of 15 December 2022 she still owns at least 48,927 units of OptiNose Inc stock.
You can see the complete history of Ms Janis stock trades at the bottom of the page.
Michele Janis MBA is the VP & Acting CFO at OptiNose Inc.
Michele's mailing address filed with the SEC is C/O OPTINOSE, INC., 1020 STONY HILL ROAD, SUITE 300, YARDLEY, PA, 19067.
Over the last 19 years, insiders at OptiNose Inc have traded over $144,654,703 worth of OptiNose Inc stock and bought 116,688 units worth $814,936 . The most active insiders traders include Sriram Venkataraman, Capital Partners Ii Gp, Llc..., and Rajat Rai. On average, OptiNose Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,645. The most recent stock trade was executed by Anthony J Krick on 17 July 2024, trading 6,845 units of OPTN stock currently worth $7,803.
optinose, inc., established in 2010 and headquartered in yardley, pennsylvania, is a publicly traded, global specialty pharmaceutical company focused on serving the needs of patients cared for by ent and allergy specialists. our team of kind, passionate, innovative people is building a new kind of organization without the encumbrances of a company with legacy systems and beliefs. we are unified by a shared mission: to improve lives. we do this while also creating great value for the healthcare system and great outcomes for our stakeholders. as innovators in every aspect of our work, we pursue faster and less costly product development, explore evolving commercial business models, and actively seek innovative ways to be more effective and efficient in all areas of the business. we operate with an overarching commitment to doing what is right. we are committed to working together as a team that chooses to live every day by core company values that guide our daily behaviors, creating a fo
OptiNose Inc executives and other stock owners filed with the SEC include: